Therapeutic Potential of Green, Synthesized Gold Nanoparticles
This study aims to use plant-leaf extract for the green synthesis of gold nanoparticles and to evaluate their antibacterial and antioxidant activity.
Kateryna_Kon/Stock.adobe.com
Gold nanoparticles (AuNPs) are important components for biomedical applications and are widely employed for diagnostics and therapeutics. Nanoparticles are mainly synthesized through chemical and physical methods, which are often costly and potentially harmful. Synthesis of nanoparticles using plants, however, is less toxic and more effective. Recently, researchers have been focusing on green synthesis of AuNPs. This study aims to use plant-leaf extract for the green synthesis of AuNPs and to evaluate their antibacterial and antioxidant activity. The results indicated that AuNPs can be synthesized using a simple method with extracts from Adiantum capillus veneris(ACV) and Pteris quadriureta(PQ) leaves. The characterization of the AuNPs was done by ultraviolet-visible spectroscopy, powder X-ray diffraction, Fourier transform infrared spectroscopy, and energy dispersive X-ray spectroscopy. The nanoparticles of ACV and PQ were seen at the wavelength of 573 nm and 520 nm, respectively. The nanoparticles of both ACV and PQ leaves extract showed antioxidant, antibacterial, and antifungal activities. ACV nanoparticles showed increased antioxidant and antimicrobial activity compared to PQ. Taken together, the results reveal that the AuNPs synthesized from leaves of ACV and PQ possesses antioxidant and antimicrobial activity.
Click here for a PDF of the article.Peer-reviewed
Submitted: July 30, 2019
Accepted: Oct. 15, 2019
About the authors
A. Usha Rajananthini, biotechurn@gmail.com, and Satabdi Rautray, rautray.satabdi@gmail.com, are with the Department of Biotechnology, Mother Teresa Women’s University, Kodaikanal, Tamil Nadu, India.
Correspondence should be addressed to both authors.
Article Details
BioPharm International
Vol. 33, No. 1
January 2020
Pages: 30–38
Citation
When referring to this article, please cite it as S. Rautray et al., “Therapeutic Potential of Green, Synthesized Gold Nanoparticles,” BioPharm International 33 (1) 2020.
VERAXA and Voyager to Create Combined Business for Advancing Pipeline of Next-Gen Cancer Therapies
April 23rd 2025The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company that will focus on developing a pipeline of next-generation cancer therapies.
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
